why choose us

First received: March 06, 2023

Clinical Trial: The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Plaque Psoriasis

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blinded, Placebo-controlled, Multicenter Phase 2 Study Evaluating the Efficacy and Safety of TLL018 in Participants With Moderate-to-severe Plaque Psoriasis

Brief Summary: This is a Phase 2, multicenter, randomized, double-blinded, parallel dose group, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of 2 doses of TLL018 as therapy in approximately 90 participants with moderate-to-severe PP.

Read more